Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 14, 2013; 19(34): 5622-5632
Published online Sep 14, 2013. doi: 10.3748/wjg.v19.i34.5622
Published online Sep 14, 2013. doi: 10.3748/wjg.v19.i34.5622
Variable | All treated patients (n= 38) | Type of TACE | P value | |
DEB-TACE (n= 22) | c-TACE (n= 16) | |||
Number of nodules per patients | 2.2 ± 1.3 | 2.2 ± 1.2 | 2.1 ± 1.4 | 0.7019 |
Untreated nodules | 21/84 (25.0) | 13/51 (25.4) | 8/33 (24.2) | 0.8934 |
Nodule number class at pathology | 0.1473 | |||
1 nodule | 17 (44.7) | 8 (36.4) | 9 (56.3) | |
1 < nodules < 4 | 14 (36.8) | 11 (50.0) | 3 (18.7) | |
≥ 4 nodules | 7 (18.4) | 3 (13.6) | 4 (25.0) | |
Sum of tumor diameters (cm) | 4.2 ± 2.8 | 4.1 ± 2.4 | 4.5 ± 3.3 | 0.5813 |
CTA (cm2) | 5.5 (0.8-78.5) | 4.6 (1.5-19.1) | 7.2 (0.8-78.5) | 0.8592 |
Necrosis on CTA | 55.2% ± 37.0% | 58.8% ± 36.6% | 50.2% ± 38.1% | 0.4856 |
Adherence to MC at pathology | 0.4250 | |||
Within MC | 31 (81.6) | 19 (86.4) | 12 (75.0) | |
Beyond MC | 7 (18.4) | 3 (13.6) | 4 (25.0) | |
Histological response | 0.2896 | |||
Appropriate (necrosis on CTA ≥ 90%) | 11 (28.9) | 8 (36.4) | 3 (18.7) | |
Partial (50% < necrosis on CTA < 90%) | 8 (21.1) | 3 (13.6) | 5 (31.3) | |
Inadequate (necrosis on CTA ≤ 50%) | 19 (50.0) | 11 (50.0) | 8 (50.0) | |
Risk factors for recurrence | ||||
Microvascular invasion | 7 (18.4) | 5 (22.7) | 2 (12.5) | 0.4271 |
1Grading > 2 | 7 (18.4) | 2/18 (11.1) | 5/14 (35.7) | 0.1948 |
-
Citation: Nicolini D, Svegliati-Baroni G, Candelari R, Mincarelli C, Mandolesi A, Bearzi I, Mocchegiani F, Vecchi A, Montalti R, Benedetti A, Risaliti A, Vivarelli M. Doxorubicin-eluting bead
vs conventional transcatheter arterial chemoembolization for hepatocellular carcinoma before liver transplantation. World J Gastroenterol 2013; 19(34): 5622-5632 - URL: https://www.wjgnet.com/1007-9327/full/v19/i34/5622.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i34.5622